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COMMENTARY
Lessons from the swamp: developing 
small molecules that confer salamander muscle 
cellularization in mammals
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Abstract: 
The ability of salamanders, such as newts, to regenerate damaged tissues has been studied for centuries. A prominent 
example of this regenerative power is the ability to re‑grow entire amputated limbs. One important step in this regen‑
eration process is skeletal muscle cellularization, in which the muscle fibers break down into dedifferentiated, mononu‑
clear cells that proliferate and form new muscle in the replacement limb. In contrast, mammalian skeletal muscle does 
not undergo cellularization after injury. A significant proportion of research about tissue regeneration in salamanders 
aims to characterize regulatory genes that may have mammalian homologs. A less mainstream approach is to develop 
small molecule compounds that induce regeneration‑related mechanisms in mammals. In this commentary, we dis‑
cuss progress in discovering small molecules that induce cellularization in mammalian muscle. New research findings 
using these compounds has also shed light on cellular processes that regulate cellularization, such as apoptotic signal‑
ing. Although formidable technical hurdles remain, this progress increases our understanding of tissue regeneration 
and provide opportunities for developing small molecules that may enhance tissue repair in humans.
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For centuries, scientists have been both fascinated and 
beguiled by the regenerative capacity of animals such as 
flatworms, starfish and salamanders [1, 2]. Among these 
species, salamanders can be thought of as the ‘champions 
of regeneration’ because they are tetrapod vertebrates 
that can completely regenerate multiple tissues, such 
as the lens, ventricle and limb, and partially regenerate 
their intestine and spinal cord ([3–5], two examples of 
salamander species are shown in Fig.  1a–b). Character-
izing the cellular and molecular mechanisms underlying 
limb regeneration responses have been the subject of 
high profile research (for example, [6–9]), with the aim of 
identifying genes or developing strategies to confer this 
ability to humans. Much progress has been made in char-
acterizing the signals and cellular responses that initiate 
and guide these regeneration processes, although our 
knowledge remains incomplete. However, it has become 
clear that there are fundamental differences in the initial 
response of mammals and salamanders to injuries such as 
limb amputation. One difference is the cellularization of 
skeletal muscle in salamanders, which contributes dedif-
ferentiated cells to a zone of regenerative cells termed the 
blastema (described below). In the context of limb regen-
eration, this had led to the development of small mole-
cules that can change the behavior of mammalian muscle 
tissue in vitro to resemble the injury response observed in 
salamanders. In this commentary, we summarize recent 
progress in the characterization of these small molecules 
and discuss their potential to be developed as therapeutic 
agents to enhance tissue regeneration in humans. Moreo-
ver, we also describe recent advances in the identification 
of new drug targets that could be used for the screening 
and development of compounds that enhance regenera-
tion responses.
There are fundamental differences in the cellular 
response of salamanders and mammals to limb ampu-
tation (discussed in [10]). In mammals, there is simple 
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closure of the wound, followed by healing and scarring. 
In salamanders, wound closure also occurs with the 
formation of a blood clot at the site of injury. However, 
within 6–12  h post-amputation, epidermal cells from 
the limb stump start to migrate and eventually cover the 
entire wound surface, forming a structure termed the 
wound epithelium (Fig.  1c). This epithelium proliferates 
to form an apical epidermal cap. The epidermis also syn-
thesizes retinoic acid, which is produced as a gradient 
across the proximal–distal axis of the blastema to pro-
vide positional identity [11–13]. The cells in the tissues 
beneath the wound cap begin to dedifferentiate, includ-
ing multinucleated skeletal muscle fibers, which break 
down into single, proliferating cells via the process of 
cellularization (Fig.  1c). Thus, the limb tissues beneath 
the amputation site revert to a mass of dedifferentiated 
cells termed the blastema [14]. A significant proportion 
of blastema cells originate from multinucleated skel-
etal muscle fibers in the limb stump [15, 16]. The blas-
tema cells proliferate and re-differentiate over a period 
of weeks to produce the tissues of the regenerating limb 
[17, 18]. Blastema cells that originated from cellularized 
muscle fibers retain memory of their tissue of origin and 
only form musculature in the regenerating limb [19]. This 
dedifferentiation does not occur in mammalian skeletal 
muscle after amputation, suggesting that cellularization 
is an important step in limb regeneration.
An interesting feature of muscle fiber cellularization 
is that it can be modelled in  vitro using skeletal mus-
cle myotubes [20]. Genetic manipulations or exoge-
nous agents that induce myotube fragmentation can be 
observed using microscopy and provide a simple assay 
for candidate compounds that produce cellularization 
in mammalian muscles [21]. The development of combi-
natorial chemistry in the 1990s provided small molecule 
libraries based on known bioactive molecules (in the 
order of thousands or tens of thousands [22]) that could 
be screened for inducers of cellularization.
The first reported success using this approach was the 
discovery of myoseverin (Table  1), which produced cel-
lularization in myotubes derived from the mouse C2C12 
myoblast cell line [23]. Myoseverin was found to bind 
tubulin in the myotubes and destabilize the cytoskeletal 
network. However, in contrast to other known tubulin 
binding molecules, myoseverin also increased the expres-
sion of genes related to the wound healing response. 
Subsequent analysis showed that myoseverin down-
regulated the myogenic transcription factor, Myf5, in 
salamander myotubes, which is also observed during 
the early stages of cellularization [24]. However, further 
Fig. 1 a–b Examples of two salamander species: the Northern red salamander (Pseudotriton ruber) and smooth newt (Triturus vulgaris). Most 
salamander species are between 10 and 20 cm in length [38]. c Role of muscle fiber cellularization in limb regeneration. After catastrophic limb 
injury, such as amputation, a wound epithelium is formed. Skeletal muscle fibers beneath the epithelium lose contact with each other and contract. 
Apoptotic signaling is initiated and the fiber undergo cellularization, which involves cell cycle re‑entry and dedifferentiation. The proliferating 
mononuclear cells contribute to a zone of proliferating cells termed the blastema, which will form the tissues of the replacement limb. Cellularized 
skeletal muscle fibers retain memory of their tissue origin and re‑differentiate into skeletal muscle in the new limb (Adapted from [39])
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studies of myoseverin using single cell analysis indicated 
that this compound may only produce myotube fragmen-
tation [25]. The mononuclear cells did not proliferate 
and remained refractory. Work from our own labora-
tory showed that further manipulation was required to 
produce cellularization, such as down-regulation of the 
cell cycle inhibitor, p21Cip1 [26]. Therefore, myoseverin 
should be categorized alongside other tubulin-binding 
molecules that cause myotube fragmentation, such as 
taxol, colchicine and nocodazole. Nevertheless, myo-
severin has been useful in the development of small 
molecule cocktails to induce cellularization (described 
below).
Numerous genetic manipulations have been shown 
to produce cellularization in mammalian myotubes, 
such as down-regulation of retinoblastoma protein (Rb) 
and Ink4a/alternative reading frame (ARF) [27], ectopic 
expression of Msx-1 [9], or overexpression of Twist [28]. 
This suggests that small molecules could be developed 
that modulate these targets in mammalian myotubes. 
The response of mammalian muscle to injuries such 
as amputation is fiber death rather than regeneration. 
Paliwal and Conboy [29] speculated that BpV, a tyros-
ine phosphatase inhibitor that delays myoblast differ-
entiation and increases proliferation, could be used to 
produce myotube cellularization. However, cell cycle 
reentry in myotube nuclei has been linked with apopto-
sis [30]. Therefore, Paliwal and Conboy combined BpV 
treatment with the apoptosis inhibitor, Q-VD (Table  1). 
Using genetically labelled mouse myotubes that express 
yellow fluorescent protein, they observed that the com-
bined chemical treatment induced cellularization, with 
approximately 10–15% of the myotube nuclei revert-
ing to proliferating mononucleated cells. Marker gene 
analysis indicated that these cells resembled myoblasts, 
with increased expression of the myogenic factors Pax7 
and MyoD. After transplantation into sites of skeletal 
muscle damage, the cells re-differentiated into muscle 
fibers, providing further evidence that combined treat-
ment with BpV and Q-VD induced reversible cellulari-
zation in mammalian myotubes. This study provided the 
first evidence that compound treatment could induce a 
prominent step of salamander limb regeneration (cellu-
larization) in mammalian muscle tissue.
A critical step in the cellularization process is the ini-
tiation of proliferation in the nuclei of the differentiated 
myotube. It can be hypothesized that small molecules 
which have been previously shown to induce prolifera-
tion in differentiated mammalian cells, such as cardiomy-
ocytes, could be combined with myotube fragmentation 
compounds to achieve cellularization. In our labora-
tory, we tested the compound, BIO (Table 1), an inhibi-
tor of glycogen syntheses kinase-3β (GSK-3β), which 
was previously shown to increase proliferation in refrac-
tory mammalian cardiac muscle cells [31, 32]. Sequential 
treatment of mouse primary myotubes with myoseverin 
and BIO induced cellularization [33]. Step-wise treat-
ment with the small molecule, reversine, an epigenetic 
regulator that produces dedifferentiation [34], induced 
pluripotent potential in the mononuclear cells as indi-
cated by re-differentiation into the neuronal lineage. The 
cell cycle inhibitor, p21Cip1 is known as a ‘gatekeeper’ that 
maintains skeletal muscle differentiation. Using three dif-
ferent small molecules that have been shown to down-
regulate p21 expression or stability; lysophosphatidic 
acid (activator of G-protein-coupled receptors), SQ22536 
(adenylyl cyclase inhibitor) and SB203580 (p38 MAP 
kinase inhibitor) (Table  1) our laboratory demonstrated 
that these molecules can induce cellularization in mouse 
C2C12 myotubes when combined with myoseverin treat-
ment [33]. This suggests that different signaling pathways 
can be manipulated to induce cellularization if they con-
verge on a common target, such as p21Cip1.
Recently, new insights about the role of chemically-
induced apoptosis in cellularization were reported [35]. 
Mammalian myotube fragmentation using myoseverin 
was shown to induce apoptosis in the mononuclear cells. 
Using the well-known apoptosis-inducing compound, 
staurosporine (Table 1), it was observed that the induc-
tion of apoptosis is a critical event in myotube frag-
mentation. However, to prevent cell death and achieve 
cellularization, the apoptotic process should be ‘inter-
cepted,’ which was achieved using the anti-apoptotic 
small molecules DIDS (inhibitor of voltage-dependent 
anionic channels) and Z-VAD or Q-VD (pancaspase 
inhibitors) (Table 1) [35]. Significantly, similar processes 
were revealed in regenerating salamander limb tissues. 
Tracing the activity of the apoptosis ‘executioner’ cleaved 
caspase-3 showed that blastema cells maintained cas-
pase activity without undergoing apoptosis. Therefore, 
sequential treatment with staurosporine and DIDS/Q-
VD produces cellularization in mammalian myotubes, 
which mimics the initiation and suppression of apoptosis 
pathways observed in the regenerating salamander limb.
Table 1 provides a list of the small molecules that have 
been used to induce cellularization in mammalian myo-
tubes. Currently, these molecules are only effective in 
combination: there is no reported single molecule treat-
ment for producing cellularization. An interesting feature 
is that, even though numerous genetic manipulations 
have been shown to achieve cellularization, such as over-
expression of Msx-1 or down-regulation of Rb/ARF [9, 
27], these molecules target different proteins, such as 
tubulin or GSK-3β. Therefore, there is ample scope to 
develop new small molecules that achieve cellularization 
by targeting known genetic regulators.
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In summary, significant progress has been achieved 
in the development of small molecules that produce 
a critical step of limb regeneration: cellularization in 
mammalian muscle tissue. Recent research indicates 
that apoptotic signaling without full progression to 
apoptosis is a significant stage of regeneration in sala-
manders. Therefore, focusing on small molecules that 
induce apoptosis in muscle, such as doxorubicin [36], 
could provide new candidate compounds for initiating 
cellularization. However, it is also apparent that major 
technical hurdles remain before there is any possibility 
of completely regenerating mammalian limb tissues. For 
example, the cellularization process has been recapitu-
lated in mammalian myotubes, but there is no data to 
suggest that this can be reproduced in fully differentiated 
mature muscle fibers, which are thicker and striated with 
contractile proteins. Moreover, small molecule-induced 
cellularization has only been reported for mouse myo-
tubes. There is no report about the effectiveness of this 
methodology in human muscle tissue. Finally, there is 
no established animal model for testing the potential for 
these small molecules to enhance tissue regeneration 
in  vivo. The p21Cip1 knockout mouse shows appendage 
regeneration with the closure of ear punctures [37]. It 
could be envisaged that small molecules which induce 
myotube cellularization by targeting p21Cip1 could be 
tested in an ear punch model using genetically normal 
mice. Overall, numerous small molecules have been 
developed that induce a key step of salamander limb 
regeneration, cellularization, in mammalian muscle tis-
sue. Unfortunately, research progress is stalled at in vitro 
analyses of myotubes derived from rodent tissues. Fur-
ther studies of these molecules in  vivo using animal 
models and confirmation of their effects in human tis-
sues are required to assess their potential to regenerate 
tissues that have been lost to injury or disease.
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